These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 28844347)

  • 41. BNIP3 expression in endometrial cancer relates to active hypoxia inducible factor 1alpha pathway and prognosis.
    Giatromanolaki A; Koukourakis MI; Gatter KC; Harris AL; Sivridis E
    J Clin Pathol; 2008 Feb; 61(2):217-20. PubMed ID: 17513511
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Corrigendum to 'A population-based study of 92 clinically recognized risk factors for heart failure: co-occurrence, prognosis and preventive potential' [Eur J Heart Fail 2022;24:466-480].
    Eur J Heart Fail; 2022 Sep; 24(9):1739. PubMed ID: 35606332
    [No Abstract]   [Full Text] [Related]  

  • 43. Growth differentiation factor 15: a novel risk marker adjunct to the EuroSCORE for risk stratification in cardiac surgery patients.
    Heringlake M; Charitos EI; Gatz N; Käbler JH; Beilharz A; Holz D; Schön J; Paarmann H; Petersen M; Hanke T
    J Am Coll Cardiol; 2013 Feb; 61(6):672-81. PubMed ID: 23391200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Application of FLASH-3D dynamic contrast-enhanced imaging for diagnosis of endometrial carcinoma.
    Du L; Li X; Qiu X; Liu X; Wang Y; Yu Y
    Br J Radiol; 2016 Oct; 89(1066):20160268. PubMed ID: 27459248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Corrigendum to "Preoperative breast cancer staging with multi-modality imaging and surgical outcomes" [Eur. J. Radiol. 122 (2020) 108766].
    Mariscotti G; Durando M; Tagliafico A; Campanino PP; Bosco D; Casella C; Bussone R; Ala A; Castellano I; Sapino A; Bergamasco L; Fonio P; Houssami N
    Eur J Radiol; 2020 May; 126():108919. PubMed ID: 32197783
    [No Abstract]   [Full Text] [Related]  

  • 46. Longer operative time is associated with increased post-operative complications in patients undergoing minimally-invasive surgery for endometrial cancer.
    Singh S; Swarer K; Resnick K
    Gynecol Oncol; 2017 Dec; 147(3):554-557. PubMed ID: 28982521
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Corrigendum to "Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer" [Eur. J. Med. Chem. 163 (2019) 787-803].
    Wang C; Wang B; Hou S; Xue L; Kang Z; Du J; Li Y; Liu X; Wang Q; Zhang C
    Eur J Med Chem; 2020 Jan; 186():111907. PubMed ID: 31791642
    [No Abstract]   [Full Text] [Related]  

  • 48. [How were used recommendations for endometrial carcinoma? Britain retrospective study].
    De Kerdaniel O; Body N; Davoine E; Foucher F; Henno S; Tavenard A; Laviolle B; Rozel C; Leblanc M; Lavoué V; Levêque J
    J Gynecol Obstet Biol Reprod (Paris); 2016 Nov; 45(9):1045-1053. PubMed ID: 26780842
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The importance of age and menopausal status in endometrial complex hyperplasia with atypia.
    Ureyen I; Karalok A; Tasci T; Turkmen O; Koc S; Ozgul A; Tulunay G; Turan T
    J Obstet Gynaecol; 2016; 36(1):102-5. PubMed ID: 26440514
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Corrigendum to "3T MRI in paediatrics: Challenges and clinical applications" [Eur. J. Radiol. 68 (2) (2008) 309-319].
    Dagia C; Ditchfield M
    Eur J Radiol; 2014 Dec; 83(12):2294. PubMed ID: 28859936
    [No Abstract]   [Full Text] [Related]  

  • 51. Robotic-assisted laparoscopic hysterectomy for women with endometrial cancer - complications, women´s experiences, quality of life and a health economic evaluation.
    Herling SF
    Dan Med J; 2016 Jul; 63(7):. PubMed ID: 27399986
    [TBL] [Abstract][Full Text] [Related]  

  • 52. L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: pooled PORTEC trial results.
    Bosse T; Nout RA; Stelloo E; Dreef E; Nijman HW; Jürgenliemk-Schulz IM; Jobsen JJ; Creutzberg CL; Smit VT
    Eur J Cancer; 2014 Oct; 50(15):2602-10. PubMed ID: 25126672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinicopathologic variables and survival comparison of patients with synchronous endometrial and ovarian cancers versus primary endometrial cancer with ovarian metastasis.
    Oranratanaphan S; Manchana T; Sirisabya N
    Asian Pac J Cancer Prev; 2008; 9(3):403-7. PubMed ID: 18990010
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Corrigendum to "A six-weekly (Q6W) dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation" [Eur J Canc 131 (2020) 68-75].
    Lala M; Li TR; de Alwis DP; Sinha V; Mayawala K; Li M; Yamamoto N; Siu LL; Chartash E; Aboshady H; Jain L
    Eur J Cancer; 2021 Feb; 144():400. PubMed ID: 33414065
    [No Abstract]   [Full Text] [Related]  

  • 55. Corrigendum to "Dissociative sensibility disorders - A retrospective case series and systematic literature review" [Eur J Paediatr Neurol (2018) 27-38].
    Weber P; Erlacher R
    Eur J Paediatr Neurol; 2018 May; 22(3):573. PubMed ID: 29548596
    [No Abstract]   [Full Text] [Related]  

  • 56. Corrigendum to "6-Amino-2,4,5-trimethylpyridin-3-ols: A new general synthetic route and antiangiogenic activity" [Eur. J. Med. Chem. 74 (2014) 126-139].
    Kim DG; Kang Y; Lee H; Lee EK; Nam TG; Kim JA; Jeong BS
    Eur J Med Chem; 2017 Dec; 141():734-735. PubMed ID: 28988929
    [No Abstract]   [Full Text] [Related]  

  • 57. Corrigendum to 'Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study' [Eur J Cancer 171 (2022) 183-192].
    Conforti F; Gronchi A; Penel N; Jones RL; Broto JM; Sala I; Bagnardi V; Napolitano A; Pala L; Pennacchioli E; Catania C; Queirolo P; Grigani G; Merlini A; Stacchiotti S; Comandone A; Vincenzi B; Quagliuolo V; Bertuzzi A; Boglione A; Palassini E; Baldi GG; Blay JY; Ryckewaert T; Toulmonde M; Italiano A; Le Cesne A; Ray-Coquard I; Cruz J; Hernández-León CN; Trufero JM; da Silva Moura D; Muñiz NH; De Pas T
    Eur J Cancer; 2023 May; 184():197-198. PubMed ID: 36907702
    [No Abstract]   [Full Text] [Related]  

  • 58. Corrigendum to "Simplified response monitoring criteria for multiple myeloma in patients undergoing therapy with novel agents using computed tomography" [Eur. J. Radiol. 85 (December (12)), 2016, 2195-2199].
    Schabel C; Horger M; Kum S; Weisel K; Fritz J; Ioanoviciu SD; Bier G
    Eur J Radiol; 2018 Jun; 103():163. PubMed ID: 29729815
    [No Abstract]   [Full Text] [Related]  

  • 59. Corrigendum to "The use of 'added benefit' to determine the price of new anti-cancer drugs in France, 2004-2017" [Eur J Canc 145 (2021) 11-18].
    Rodwin MA; Mancini J; Duran S; Jalbert AC; Viens P; Maraninchi D; Gonçalves A; Marino P
    Eur J Cancer; 2021 Jul; 152():259-261. PubMed ID: 33994018
    [No Abstract]   [Full Text] [Related]  

  • 60. Corrigendum to "Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial" [Eur J Cancer 87 (2017) 122-130].
    Verlingue L; Malka D; Allorant A; Massard C; Ferté C; Lacroix L; Rouleau E; Auger N; Ngo M; Nicotra C; De Baere T; Tselikas L; Ba B; Michiels S; Scoazec JY; Boige V; Ducreux M; Soria JC; Hollebecque A
    Eur J Cancer; 2018 Apr; 93():156-157. PubMed ID: 29454743
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.